A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine
PHASE1
A phase I prospective, randomized study in healthy adult subjects at a sing...
Status
Completed
Location
University of Rochester Medical Center - Vaccine Research Unit
Safety and Immunogenicity of Priming With Live Attenuated A/H7N9 Influenza Virus Vaccine Followed By Inactivated A/H7N9 Influenza Virus Vaccine With AS03 Adjuvant
PHASE1
The purpose of this study is to evaluate the safety and immunogenicity of o...
A Study in Healthy Adults to Assess Priming With Antigenically Mismatched Live Attenuated A/H7N3 Influenza Virus Vaccine Followed by Inactivated A/H7N9 Influenza Virus Vaccine
PHASE1
The purpose of this study is to assess priming with antigenically mismatche...
Status
Completed
Location
University of Rochester Medical Center Vaccine Research Unit (Outpatient)